- All sections
- C - Chemistry; metallurgy
- C07K - Peptides
- C07K 5/02 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
Patent holdings for IPC class C07K 5/02
Total number of patents in this class: 737
10-year publication summary
|
66
|
59
|
77
|
67
|
72
|
49
|
35
|
49
|
45
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| SeaGen Inc | 580 |
23 |
| Janssen Pharmaceutica N.V. | 3625 |
14 |
| Revolution Medicines, Inc. | 200 |
14 |
| ImmunoGen, Inc. | 406 |
13 |
| Endocyte, Inc. | 111 |
11 |
| Kyowa Hakko Bio Co., Ltd. | 303 |
11 |
| F. Hoffmann-La Roche AG | 7942 |
10 |
| Hoffmann-La Roche Inc. | 3252 |
10 |
| Novartis AG | 11297 |
9 |
| Siemens Medical Solutions USA, Inc. | 1542 |
8 |
| President and Fellows of Harvard College | 5904 |
8 |
| Pfizer Inc. | 3373 |
7 |
| Merck Patent GmbH | 5849 |
7 |
| Ajinomoto Co., Inc. | 2316 |
7 |
| Cornell University | 3184 |
7 |
| Dana-Farber Cancer Institute, Inc. | 2531 |
7 |
| Zymeworks Inc. | 243 |
7 |
| The Regents of the University of California | 19479 |
6 |
| Centre National de La Recherche Scientifique | 10052 |
6 |
| Ambrx, Inc. | 192 |
6 |
| Other owners | 546 |